Sanofi is a global healthcare company. Among their duties are researching disease causes, determining starting points for drug treatment, developing drugs, producing active ingredients, and delivering finished drugs and active ingredients. Specialists in vaccines, rare diseases, rare blood disorders, neurology, immunology, oncology, diabetes, cardiovascular diseases, and consumer healthcare.

JAAN Biotherapeutics is a private company that is developing novel therapies to activate the cardiac regeneration process in diseased hearts

Genetrix SL develops biotechnological solutions. It is comprised of technology and biomedicine companies in order to maximize the value of the Group. The company was founded in May 20, 2003 and is headquartered in Madrid, Spain.

Academisch Ziekenhuis Maastricht operates as medical research centre. The company is headquartered in Maastricht, the Netherlands.

International Centre For Genetic Engineering & Biotechnology is an Italian private company. The firm operates as a center for genetic engineering and biotechnology.

Beth Israel Deaconess Medical Center (BIDMC) in Boston, Massachusetts is a teaching hospital of Harvard Medical School. It was formed out of the 1996 merger of Beth Israel Hospital (founded in 1916) and New England Deaconess Hospital (founded in 1896). Among independent teaching hospitals, Beth Israel Deaconess Medical Center consistently ranks in the top three recipients of biomedical research funding from the National Institutes of Health. Research funding totals nearly $200 million annually. BIDMC researchers run more than 850 active sponsored projects and 200 clinical trials. The Harvard-Thorndike General Clinical Research Center, the oldest clinical research laboratory in the United States, has been located on this site since 1973.

Aventis Pharma Deutschland GmbH produces pharmaceutical products. It offers prescription drugs, human vaccines, and therapeutic proteins businesses. Aventis Pharma Deutschland plans and designs plants and process control systems in the areas of active ingredients production and finished drugs. The company is headquartered in Frankfurt am Main, Germany.

Animatus Biosciences develops technology that can control networks of genes to regenerate cardiac tissue. Their two mRNA combinations, AN-153, are modified to make altered proteins that regulate key cellular pathways in cardiac cells.

The Board of Regents of The University of Texas System, a subsidiary of The University of Texas at Austin, is an American company located in Austin, TX. The firm oversees college activities.

University Health Network (UHN) is a healthcare and medical research organization in Toronto, Ontario, Canada. It is the largest such research organization in Canada and North America, ranking first in Canada for total research funding. It was named Canada's top research hospital by Research Infosource in 2015, 2016 and 2017. It was created in 1986 by the Government of Ontario through the merger of four major hospitals: Toronto General Hospital, Toronto Western Hospital, with the Princess Margaret Cancer Centre, and the Toronto Rehabilitation Institute merged in with The Toronto Hospital in 1999 and the name changed to the University Health Network. All four hospitals are affiliated with the Faculty of Medicine at the University of Toronto and serve as teaching hospitals for resident physicians, nurses, and other healthcare professions. UHN also operates The Michener Institute, an applied health sciences college that opened in 1958.

The Victor Chang Cardiac Research Institute is an independent, not-for-profit research facility, dedicated to the memory of cardiac surgeon Dr Victor Chang and his passionate belief in the power of discovery. Founded in 1994, the Institute has grown to become a world-class cardiac research and research training facility. Their team of over 150 full-time staff work across five main Research Divisions – Cardiac Physiology & Transplantation, Developmental and Stem Cell Biology, Molecular Cardiology & Biophysics, Vascular Biology and Molecular, Structural & Computational Biology. They hold ourselves to the highest standards of excellence in their research, research training and efforts to translate each new discovery into practical medical applications.

SL BIGEN is a research and development business that aims to save patients' lives through bio-genetic engineering. SL BIGEN is working on two projects: I a first-in-class mesenchymal stem cell line engineered to express disease-specific therapeutic genes, and (ii) a multi-engineered natural killer cell line expressing fourth generation chimeric antigen receptors. Cancer and neurological illnesses are among the therapeutic areas covered by the company.

Rolith is developing advanced nanostructured products for consumer electronics, solar and green building markets using a proprietary nanolithography technology. Its Rolling Mask nanostructuring system surpasses current nanolithography systems in throughput, cost and quality. Rolith was formed by Dr. Boris Kobrin, Prof. Mark Brongersma and Julian Zegelman in 2008 and is currently located in Pleasanton, CA. The company holds a comprehensive patent portfolio in the areas of nanolithography, material deposition and etch methods, and nanophotonic devices. Rolith's strategic partners include SUSS MicroTec AG and Asahi Glass Group. It is backed by DFJ VTB Capital Aurora (DFJ affiliate fund managed by VTB Capital) and AGC America, Inc. (venture arm of Asahi Glass Group).

Yeda Research and Development Company Ltd. is the commercial arm of the Weizmann Institute of Science. Yeda holds an exclusive agreement with the Weizmann Institute to commercialize the unique intellectual property developed by the scientists. The income generated serves to support further basic research and science education. - Identify and assess research projects with commercial potential. - Protect the intellectual property of the Institute and its scientists. - Create business relationships and license the Institute’s inventions and technologies to the industry. - Channel funding from industry to research projects. For further information please contact Tamir Huberman, CIO and Head of Marketing

Shanghai Essence Biotechnology Co., Ltd., established on 2018-05-17, Business scope includes licensed projects:Import and export,Technology Import and Export,Class III medical device business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments) General project:Engaged in technology development in the field of biotechnology,technology transfer,technical consulting,Technical Services,biological reagent(Removal of hazardous chemicals,medicine,veterinary medicine),laboratory equipment,Instrumentation,Chemical raw materials and products(Removal of hazardous chemicals,Monitor Chemicals,firecrackers,civilian explosives,precursor chemicals),crafts(Except for ivory and its products),Sales of Class I Medical Devices,Wholesale of Class II Medical Devices,Cosmetics Wholesale,Wholesale of kitchenware, sanitary ware and daily sundries,Labor insurance supplies wholesale.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

Ventritex, Inc. designs, develops, manufactures and markets implantable defibrillators and related products for the treatment of ventricular tachycardia and ventricular fibrillation.

Creative Medical Technologies, Inc. develops novel regenerative medicine and stem cell technologies. The company was founded on December 3, 1998 and is headquartered in Phoenix, AZ.